Synlogic Taps Andrew Gengos for Chief Operating Officer Post

Xconomy Boston — 

Andrew Gengos has been named chief operating officer and head of corporate development for Cambridge, MA, biotech Synlogic (NASDAQ: SYBX). Gengos was most recently president and CEO of Westlake Village, CA-based ImmunoCellular Therapeutics (NYSE MKT: IMUC). Synlogic, which genetically engineers microbes for therapeutic applications, went public earlier this year in a reverse merger.